NeuroMolecular Medicine
http://www.springerlink.com/content/120555/

NeuroMolecular Medicine (part B of the Journal of Molecular Neuroscience) publishes cutting-edge original research articles and critical reviews on the molecular and biochemical basis of neurological disorders. Studies range from genetic analyses of human populations to animal and cell culture models of neurological disorders. Emerging findings concerning the identification of genetic aberrancies and their pathogenic mechanisms at the molecular and cellular levels will be included. Also covered are experimental analyses of molecular cascades involved in the development and adult plasticity of the nervous system, in neurological dysfunction, and in neuronal degeneration and repair. NeuroMolecular Medicine encompasses basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death. The journal also gives special attention to synthetic research and reviews that aim to bridge genetic aberrancies with cellular and molecular mechanisms of neurological pathogenesis. The information published in NMM will provide a window into the future of molecular medicine for the nervous system. Mark Mattson has been coeditor of the Journal of Molecular Neuroscience and is now, with Christine van Broeckhoven and John Hardy, developing a more focused venue for the molecular genetics, biochemistry and cell biology of neurological disorders. NeuroMolecular Medicine is committed to publishing high quality original research and critical reviews in these exciting areas of research.